Therapeutic drug monitoring (TDM) in patients with inflammatory bowel disease (IBD) as an example of the development of theranostics - Personalized precision medicine

被引：0
|
作者：
Podstawka, I. [1 ]
Skorupa, E. [1 ]
Ochocinska, A. M. [1 ]
Wlazlo, M. [2 ]
Meglicka, M. [2 ]
机构：
[1] Childrens Mem Hlth Inst, Dept Clin Biochem, Warsaw, Poland
[2] Childrens Mem Hlth Inst, Dept Gastroenterol Hepatol Feeding Disorders & Pe, Warsaw, Poland
来源：
CLINICA CHIMICA ACTA | 2024年 / 558卷
关键词：
D O I：
10.1016/j.cca.2024.119494
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
P1654
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Clinical value of routine therapeutic anti-TNF drug monitoring (TDM) in Inflammatory Bowel Disease (IBD) patients in clinical practice
    Guirgis, M.
    Bianchetti, D.
    Dorta, G.
    Michetti, P.
    Maillard, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 : S235 - S236
  • [2] Personalized Medicine of Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacogenetics, Therapeutic Drug Monitoring, and Beyond
    Di Paolo, Antonello
    Luci, Giacomo
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [3] Therapeutic drug monitoring in patients with inflammatory bowel disease
    Andres J Yarur
    Maria T Abreu
    Amar R Deshpande
    David H Kerman
    Daniel A Sussman
    [J]. World Journal of Gastroenterology, 2014, (13) : 3475 - 3484
  • [4] Therapeutic drug monitoring in patients with inflammatory bowel disease
    Yarur, Andres J.
    Abreu, Maria T.
    Deshpande, Amar R.
    Kerman, David H.
    Sussman, Daniel A.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (13) : 3475 - 3484
  • [5] Update on TDM (Therapeutic Drug Monitoring) with Ustekinumab, Vedolizumab and Tofacitinib in Inflammatory Bowel Disease
    Restellini, Sophie
    Afif, Waqqas
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (06) : 1 - 16
  • [6] CLINICAL IMPLEMENTATION OF PERSONALIZED MEDICINE BY NOVEL APPROACHES IN THERAPEUTIC DRUG MONITORING (TDM)
    Eliasson, E.
    Pohanka, A.
    Dahl, M. -L
    Lindh, J.
    Beck, O.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 13 - 13
  • [7] Therapeutic Drug Monitoring of Adalimumab in Patients With Inflammatory Bowel Disease
    El-Matary, Wael
    [J]. CROHNS & COLITIS 360, 2019, 1 (03)
  • [8] Therapeutic Drug Monitoring in Inflammatory Bowel Disease Patients on Vedolizumab
    Ansari, Mohammed
    Glassner, Kerri
    Irani, Malcolm
    Perry, Caroline
    Abraham, Bincy P.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S435 - S436
  • [9] Therapeutic drug monitoring in patients with inflammatory bowel disease on ustekinumab
    Saleh, Adam
    Stading, Rachel
    Miroballi, Natalia
    Glassner, Kerri
    Abraham, Bincy P.
    [J]. JOURNAL OF DIGESTIVE DISEASES, 2024, 25 (04) : 214 - 221
  • [10] Therapeutic drug monitoring in inflammatory bowel disease patients on vedolizumab
    Ansari, Mohammed
    Glassner, Kerri
    Irani, Malcolm
    Saleh, Adam
    Wang, Lin
    Ezeana, Chika
    Wong, Stephen
    Perry, Caroline
    Abraham, Bincy
    [J]. JOURNAL OF DIGESTIVE DISEASES, 2024, 25 (02) : 91 - 99
12345